OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 123 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 1.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $516,000 | -23.6% | 1,200,000 | 0.0% | 0.09% | -31.3% |
| Q1 2016 | $675,000 | -67.0% | 1,200,000 | +0.9% | 0.13% | -56.6% |
| Q4 2015 | $2,045,000 | -18.5% | 1,189,000 | 0.0% | 0.31% | -22.8% |
| Q3 2015 | $2,509,000 | -35.8% | 1,189,000 | +50.7% | 0.40% | -14.7% |
| Q2 2015 | $3,906,000 | -40.0% | 789,000 | -5.1% | 0.47% | -57.3% |
| Q1 2015 | $6,513,000 | +186.5% | 831,800 | +121.8% | 1.10% | +66.6% |
| Q4 2014 | $2,273,000 | +8.0% | 375,000 | -24.1% | 0.66% | +7.0% |
| Q3 2014 | $2,104,000 | +13.4% | 494,000 | +64.6% | 0.62% | +12.0% |
| Q2 2014 | $1,855,000 | -13.3% | 300,199 | -8.8% | 0.55% | -14.3% |
| Q1 2014 | $2,140,000 | +52.0% | 329,199 | +31.7% | 0.64% | +16.5% |
| Q4 2013 | $1,408,000 | – | 250,000 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,250,000 | $7,725,000 | 6.48% |
| Ghost Tree Capital, LLC | 250,000 | $1,545,000 | 1.09% |
| Rock Springs Capital Management LP | 905,000 | $5,593,000 | 1.00% |
| Palo Alto Investors LP | 1,931,324 | $11,936,000 | 0.89% |
| PFM Health Sciences, LP | 4,604,958 | $28,459,000 | 0.57% |
| NEA Management Company, LLC | 1,935,300 | $11,960,000 | 0.56% |
| Rhenman & Partners Asset Management AB | 300,199 | $1,855,000 | 0.55% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 1,752,792 | $10,832,000 | 0.50% |
| CQS Cayman LP | 660,040 | $4,079,000 | 0.25% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,684,300 | $16,589,000 | 0.24% |